EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first ...
EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...
2025 — An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new ... Advanced Imaging Uncovers Hidden Metastases in High-Risk ...
On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...
Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision medicines to treat ...
6d
16."When I was in med school, there was a guy in his early 60s, fairly healthy, who kept coming into the hospital with vague ...
Miniature terahertz sensor detects cancer types with record sensitivity and no chemical preparation, advancing accessible ...
GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company, and 3D Imaging LLC (3DI), a Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals, are ...
The global interventional radiology products market is on the verge of significant expansion, fueled by technological innovations and cutting-edge techniques revolutionizing the field. With an ...
FWMOH operates nine locations across northeastern Indiana and is staffed by 16 Board-certified medical oncologists and two ...
All rights reserved. Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP. A Charity, Not for Profit. Company Limited by Guarantee. Registered in England No.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback